Image
Kim Bullock, MD

Kim Bullock, MD

Clinical Professor, Psychiatry and Behavioral Sciences
Member, Wu Tsai Human Performance Alliance
Certified Clinician, DBT-Linehan Board of Certification, Dialectical Behavior Therapy (2022)
Board Certification: American Board of Lifestyle Medicine, Lifestyle Medicine (2017)
Board Certification: United Council for Neurologic Subspecialties, Behavioral Neurology and Neuropsychiatry (2012)
Residency: Stanford University Psychiatry and Behavioral Sciences (2002) CA
Medical Education: George Washington University School of Medicine and Health Sciences (1994) DC
Certification, American Board of Lifestyle Medicine, Lifestyle Medicine (2017)
Residency, Stanford University, Psychiatry (2002)
Internship, Washington Hospital Center, Internal Medicine (1995)
MD, George Washington University, Medicine (1994)
BA, University of California, Animal Physiology (1989)
BA, University of California, Psychology (1989)
Kim Bullock received her undergraduate degree with honors and distinction in physiology and psychology from the University of California, San Diego, Revelle College and her medical degree from George Washington University in Washington, DC. She completed an Internal Medicine internship at Washington Hospital in D.C. and psychiatry residency at Stanford University. She is a diplomat in the subspecialties of Behavioral Neurology and Neuropsychiatry and Lifestyle Medicine. She is also an intensively trained DBT-Linehan Board-certified clinician. She is appointed Clinical Professor in the Department of Psychiatry and Behavioral Sciences within Stanford’s School of Medicine, where she founded and directs the Virtual Reality & Immersive Technology (VRIT) clinic and program. She has published multiple peer-reviewed articles and is a Cambridge and Oxford Press author. She is currently the president of the Society for Immersive Mental Health (SIMH), an international medical society dedicated to supporting the safe and effective development of immersive technology into the care of those with mental illness.

Dr. Bullock is a clinician, teacher, and researcher who focuses on using novel approaches and technologies to address traditional mental health problems. Her original research involved adapting group and individual Cognitive Behavior Therapy (CBT) for persons with Functional Neurological Disorder (FND). Dr. Bullock still works in these group settings teaching and delivering interventions for neuropsychiatric illnesses and has developed and reported on the adaptation of group dialectical behavior therapy skills training (DBT-ST) as a treatment for adults with FND many with psychogenic non-epileptic seizures (PNES). She founded and also directs the DBT4FND clinic.

Dr. Bullock’s research on novel CBT adaptations expanded and led to the establishment of Stanford’s VRIT clinic and lab in 2015. Her work now includes a broader focus on the development, integration, application and scaling of immersive technologies into all of psychiatric care. This includes designing, testing, and implementing VR-based interventions for populations with significant depression, phobias, anxiety disorders, eating disorders, hoarding disorder, and many other psychiatric illnesses. Dr. Bullock’s clinical work most often augments traditional evidence-based therapies with XR applications to improve clinical outcomes, patient engagement, and skills acquisition. Her current studies are looking at the enhancement of traditional behavioral activation with extended reality (XR) for Major Depressive Disorder in specific populations.

Dr. Bullock takes a holistic, nonjudgmental, customized, and personal approach to each patient and encourages family, culture, and community involvement. She believes that most illnesses are multifactorial in nature and should be approached in diverse ways.

Dr. Bullock hosts a monthly podcast on the topic of Immersive Technology and Psychiatry can be found at: https://www.psychiatryxr.com/
https://stanfordvrit.org/
https://med.stanford.edu/psychiatry/patient_care/vrit.html
https://med.stanford.edu/content/dam/sm/psychiatry/documents/clinical/fnd/SHCDBT4FND.pdf